» Articles » PMID: 37616338

Chlorogenic Acid Ameliorates Post-Infectious Irritable Bowel Syndrome by Regulating Extracellular Vesicles of Gut Microbes

Overview
Journal Adv Sci (Weinh)
Date 2023 Aug 24
PMID 37616338
Authors
Affiliations
Soon will be listed here.
Abstract

Post-infectious irritable bowel syndrome (PI-IBS) occurs after acute infectious diarrhea, and dysbiosis can be involved in its pathogenesis. Here, the role of chlorogenic acid (CGA) is investigated, a natural compound with several pharmacological properties, in alleviating PI-IBS in rats. It is elucidated that the gut microbiota plays a key role in PI-IBS pathogenesis and that rectal administration of CGA alleviated PI-IBS by modulating the gut microbiota and its metabolites. CGA supplementation significantly increased fecal Bacteroides acidifaciens abundance and glycine levels. Glycine structurally altered B. acidifaciens extracellular vesicles (EVs) and enriched functional proteins in the EVs; glycine-induced EVs alleviated PI-IBS by reducing inflammation and hypersensitivity of the intestinal viscera and maintaining mucosal barrier function. Moreover, B. acidifaciens EVs are enriched in the brain tissue. Thus, CGA mediates the mitigation of PI-IBS through the gut microbiota and its metabolites. This study proposes a novel mechanism of signal exchange between the gut microenvironment and the host.

Citing Articles

ScRNA-seq unveils the functional characteristics of glioma-associated macrophages and the regulatory effects of chlorogenic acid on the immune microenvironment-a study based on mouse models and clinical practice.

Wang J, Li S, Chen Y, Chen J, Wang C, Kang Z Front Immunol. 2025; 15:1494806.

PMID: 39867913 PMC: 11757274. DOI: 10.3389/fimmu.2024.1494806.


The Role of Gut Microbiome in Irritable Bowel Syndrome: Implications for Clinical Therapeutics.

Zhao Y, Zhu S, Dong Y, Xie T, Chai Z, Gao X Biomolecules. 2025; 14(12.

PMID: 39766350 PMC: 11674646. DOI: 10.3390/biom14121643.


Insights into Microbiota-Host Crosstalk in the Intestinal Diseases Mediated by Extracellular Vesicles and Their Encapsulated MicroRNAs.

Zeng Y, Yin Y, Zhou X Int J Mol Sci. 2024; 25(23.

PMID: 39684711 PMC: 11641152. DOI: 10.3390/ijms252313001.


Target fishing and mechanistic insights of the natural anticancer drug candidate chlorogenic acid.

Wang Q, Du T, Zhang Z, Zhang Q, Zhang J, Li W Acta Pharm Sin B. 2024; 14(10):4431-4442.

PMID: 39525590 PMC: 11544177. DOI: 10.1016/j.apsb.2024.07.005.


Intranasal administration of and its derived extracellular vesicles alleviate LPS-induced acute lung injury.

Liu L, Zheng C, Xu Z, Wang Z, Zhong Y, He Z Microbiol Spectr. 2024; :e0210824.

PMID: 39472001 PMC: 11619349. DOI: 10.1128/spectrum.02108-24.


References
1.
Grabauskas G, Gao J, Wu X, Zhou S, Turgeon D, Owyang C . WITHDRAWN: Gut Microbiota Alter Visceral Pain Sensation and Inflammation via Modulation of Synthesis of Resolvin D1 in Colonic Tuft Cells. Gastroenterology. 2022; . PMC: 9898459. DOI: 10.1053/j.gastro.2022.07.053. View

2.
Shao Y, Guo Y, Feng X, Liu J, Chang Z, Deng G . Oridonin Attenuates TNBS-induced Post-inflammatory Irritable Bowel Syndrome via PXR/NF-κB Signaling. Inflammation. 2020; 44(2):645-658. DOI: 10.1007/s10753-020-01364-0. View

3.
Xia C, Jiang C, Li W, Wei J, Hong H, Li J . A Phase II Randomized Clinical Trial and Mechanistic Studies Using Improved Probiotics to Prevent Oral Mucositis Induced by Concurrent Radiotherapy and Chemotherapy in Nasopharyngeal Carcinoma. Front Immunol. 2021; 12:618150. PMC: 8024544. DOI: 10.3389/fimmu.2021.618150. View

4.
Deng C, Zheng J, Zhou H, You J, Li G . Dietary glycine supplementation prevents heat stress-induced impairment of antioxidant status and intestinal barrier function in broilers. Poult Sci. 2022; 102(3):102408. PMC: 9827071. DOI: 10.1016/j.psj.2022.102408. View

5.
He S, Guo Y, Zhao J, Xu X, Wang N, Liu Q . Ferulic Acid Ameliorates Lipopolysaccharide-Induced Barrier Dysfunction MicroRNA-200c-3p-Mediated Activation of PI3K/AKT Pathway in Caco-2 Cells. Front Pharmacol. 2020; 11:376. PMC: 7145943. DOI: 10.3389/fphar.2020.00376. View